Description
BSE announces listing of 4,48,889 new equity shares of Vivo Bio Tech Ltd issued to promoters through preferential allotment via warrant conversion, effective August 8, 2025.
Summary
BSE has approved the listing of 4,48,889 new equity shares of Vivo Bio Tech Ltd (Scrip Code: 511509) issued to promoters through preferential allotment pursuant to warrant conversion. The shares will commence trading on August 8, 2025, and are subject to lock-in restrictions until February 28, 2027.
Key Points
- 4,48,889 equity shares of Rs. 10/- each issued at Rs. 35/- premium
- Issued to promoters on preferential basis through warrant conversion
- Shares rank pari-passu with existing equity shares
- Distribution numbers: 17475928 to 17924816
- Allotment date: April 17, 2025
- Issue price: Rs. 45/- per share
Regulatory Changes
No regulatory changes announced in this circular.
Compliance Requirements
- Trading members must note the new securities for trading operations
- Lock-in restrictions apply to all 4,48,889 shares until February 28, 2027
- Shares cannot be transferred or traded by promoters during lock-in period
Important Dates
- Trading Commencement: August 8, 2025
- Allotment Date: April 17, 2025
- Lock-in Expiry: February 28, 2027
Impact Assessment
Minimal immediate market impact as shares are subject to promoter lock-in restrictions until 2027. The preferential allotment increases promoter shareholding and strengthens company’s equity base. Trading liquidity remains unaffected as locked-in shares cannot be traded in the secondary market.
Impact Justification
Routine listing of new shares from warrant conversion with limited market impact due to promoter lock-in until 2027